RH
RHHBY
HealthcareRoche Holding AG
Drug Manufacturers - General
Total Trades
4
Unique Traders
3
Purchases / Sales
1/3
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jul 11, 2025 |  Ritchie John TorresD | Stock | Sell | $1,001 - $15,000 | $40.49 | $38.23 | -5.6% | -7.8% | |
Apr 21, 2025 |  Bruce WestermanR | Stock | Sell | $1,001 - $15,000 | $38.80 | $39.39 | +1.5% | -11.9% | |
Apr 9, 2025 |  Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $37.10 | $38.37 | +3.4% | +0.6% | |
Mar 3, 2025 | Bruce WestermanR | Stock | Buy | $1,001 - $15,000 | $40.48 | $39.37 | -2.8% | +0.3% |
Recent News
Sarepta: Safety And Efficacy Flaws Undermine Gains On Restructuring News
SeekingAlpha-Invalid Date
Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
Yahoo-Invalid Date
Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 | Advancements in Anti-VEGF Therapies Driving Progress in Treatments
Yahoo-Invalid Date
Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research
Yahoo-Invalid Date
Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information
Yahoo-Invalid Date